Literature DB >> 15057429

The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation.

Franz Rödel1, Ulrich Schaller, Stefan Schultze-Mosgau, Horst-Ulrich Beuscher, Ludwig Keilholz, Martin Herrmann, Reinhard Voll, Rolf Sauer, Guido Hildebrandt.   

Abstract

BACKGROUND AND
PURPOSE: Low-dose radiotherapy (LD-RT) is known to exert an anti-inflammatory effect, but the knowledge of the underlying molecular mechanisms is still scarce. The authors have recently reported that transforming growth factor beta 1 (TGF-beta(1)) essentially contributes to a reduced endothelial adhesion of mononuclear cells (PBMC) following LD-RT. Furthermore, TGF-beta(1) secretion was associated with the induction of the transcription factor nuclear factor kappa B (NF-kappaB). However, the time course of adhesion, TGF-beta(1) expression, and NF-kappaB activity following LD-RT has not been thoroughly investigated yet.
MATERIAL AND METHODS: The human EA.hy.926 endothelial cell line (EA.hy.926 EC) was grown to 95% confluence. Immediately after stimulation with the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-alpha), EA.hy.926 EC were irradiated with single doses ranging from 0.3 up to 3 Gy. Adhesion assays were performed 4, 12, and 24 h after irradiation. Nuclear extracts and culture supernatants were harvested after 4, 8, 12, 20, 24, 30, and 40 h. NF-kappaB DNA-binding activity was analyzed by electrophoretic mobility shift assays (EMSA) and TGF-beta(1) secretion by enzyme-linked immunosorbent assay (ELISA). The functional impact of TGF-beta(1) on the course of leukocyte/EC adhesion was analyzed by neutralizing TGF-beta(1) in parallel with stimulation/irradiation of the EA.hy.926 EC.
RESULTS: 4 and 24 h after irradiation of EA.hy.926 EC in the dose range between 0.3 and 0.7 Gy, a reduced adhesion of PBMC compared to nontreated controls could be observed. However, 12 h after irradiation a relative maximum of adhesion (up to 30% increase) was seen at a dose of 0.3 Gy. TGF-beta(1) secretion and NF-kappaB DNA-binding activity displayed a similar biphasic kinetics of induction with a relative minimum 12 h after irradiation. Neutralization of TGF-beta(1) activity restored adhesion at 4 and 24 h after LD-RT of EA.hy.926 EC, but it did not influence leukocyte adhesion 12 h after irradiation.
CONCLUSION: LD-RT of stimulated human EA.hy.926 EC is followed by a biphasic time course of NF-kappaB activity and an increased secretion of TGF-beta(1). The kinetics shows peak levels at 4-8 h and 24-30 h after LD-RT and results in a biphasic leukocyte/EC adhesion profile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057429     DOI: 10.1007/s00066-004-1237-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Radiotherapy of indolent orbital lymphomas : Two radiation concepts.

Authors:  Laila König; Robert Stade; Juliane Rieber; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2016-05-09       Impact factor: 3.621

Review 2.  Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.

Authors:  M Arenas; S Sabater; V Hernández; A Rovirosa; P C Lara; A Biete; J Panés
Journal:  Strahlenther Onkol       Date:  2012-08-22       Impact factor: 3.621

3.  Successful treatment of chronic recurrent multifocal osteomyelitis using low-dose radiotherapy : A case report.

Authors:  Christian T Dietzel; Christoph Schäfer; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2016-11-07       Impact factor: 3.621

4.  Radiation therapy for early stages of morbus Ledderhose.

Authors:  Reinhard Heyd; Anne Pia Dorn; Markus Herkströter; Claus Rödel; Marcus Müller-Schimpfle; Ingeborg Fraunholz
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

5.  Calcifying tendonitis of the shoulder joint : predictive value of pretreatment sonography for the response to low-dose radiotherapy.

Authors:  Boris Adamietz; Rüdiger Schulz-Wendtland; Sedat Alibek; Michael Uder; Rolf Sauer; Oliver Ott; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

6.  Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial.

Authors:  O J Ott; C Jeremias; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

7.  Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.

Authors:  Laila König; Juliane Hörner-Rieber; Denise Bernhardt; Adriane Hommertgen; Stefan Rieken; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

8.  Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation.

Authors:  Franz Rödel; Benjamin Frey; Katrin Manda; Guido Hildebrandt; Stephanie Hehlgans; Ludwig Keilholz; M Heinrich Seegenschmiedt; Udo S Gaipl; Claus Rödel
Journal:  Front Oncol       Date:  2012-09-25       Impact factor: 6.244

9.  Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.

Authors:  Karin M Hardiman; Jianhua Liu; Ying Feng; Joel K Greenson; Eric R Fearon
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

10.  How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Authors:  Yvonne Rubner; Roland Wunderlich; Paul-Friedrich Rühle; Lorenz Kulzer; Nina Werthmöller; Benjamin Frey; Eva-Maria Weiss; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.